Effects of the Histone Deacetylase Inhibitor ITF2357 in Autoinflammatory Syndromes

相似書籍

• The Oral Histone Deacetylase Inhibitor ITF2357 Reduces Cytokines and Protects Islet β Cells In Vivo and In Vitro
  由: Lewis, Eli C, et al.
  出版: (2011)
• The Histone Deacetylase Inhibitor ITF2357 Reduces Production of Pro-Inflammatory Cytokines In Vitro and Systemic Inflammation In Vivo
  由: Leoni, Flavio, et al.
  出版: (2005)
• Histone deacetylase inhibitor ITF2357 leads to apoptosis and enhances doxorubicin cytotoxicity in preclinical models of human sarcoma
  由: Di Martile, Marta, et al.
  出版: (2018)
• Pharmacokinetics, Safety and Inducible Cytokine Responses during a Phase 1 Trial of the Oral Histone Deacetylase Inhibitor ITF2357 (Givinostat)
  由: Furlan, Antonio, et al.
  出版: (2011)
• Class I and II Histone Deacetylase Inhibition by ITF2357 Reduces SLE Pathogenesis In Vivo
  由: Regna, Nicole L., et al.
  出版: (2014)